Ascend scolded—again—for estrogen drug promos in OPDP's 4th warning this year
admin 29th August 2018 Uncategorised 0The FDA’s promo police are back in action with their fourth untitled letter of the year—and it’s a second for Ascend Therapeutics’ estrogen therapy EstroGel, previously taken to task in 2015.
More: Ascend scolded—again—for estrogen drug promos in OPDP's 4th warning this year
Source: fierce